Glory Health Industry 과거 수익 실적

과거 기준 확인 0/6

Glory Health Industry의 수입은 연평균 -65.2%의 비율로 감소해 온 반면, Real Estate 산업은 수입이 연평균 1%의 비율로 감소했습니다. 매출은 연평균 23%의 비율로 감소해 왔습니다.

주요 정보

-65.2%

수익 성장률

-65.2%

EPS 성장률

Real Estate 산업 성장	2.8%
매출 성장률	-23.0%
자기자본 수익률	-2.8%
순이익	-17.5%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

수익 및 비용 분석

Glory Health Industry 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

SEHK:2329 수익, 비용 및 수입 (CNY Millions )
날짜	수익	수익	G+A 비용
30 Jun 24	2,037	-356	371
31 Mar 24	2,272	-460	403
31 Dec 23	2,506	-564	434
30 Sep 23	2,461	-531	463
30 Jun 23	2,415	-497	492
31 Mar 23	3,160	-705	510
31 Dec 22	3,905	-913	529
30 Sep 22	5,087	-817	645
30 Jun 22	6,270	-721	761
31 Mar 22	8,084	-246	756
31 Dec 21	9,898	228	751
30 Sep 21	9,460	261	704
30 Jun 21	9,021	294	657
31 Mar 21	7,395	196	699
31 Dec 20	5,769	99	741
30 Sep 20	6,705	301	775
30 Jun 20	7,641	502	808
31 Mar 20	7,867	681	836
31 Dec 19	8,093	860	863
30 Sep 19	8,121	943	859
30 Jun 19	8,149	1,027	854
31 Mar 19	7,381	1,018	784
31 Dec 18	6,612	1,009	715
30 Sep 18	6,728	1,335	641
30 Jun 18	6,844	1,662	567
31 Mar 18	6,816	1,706	561
31 Dec 17	6,787	1,750	556
30 Sep 17	6,674	1,474	578
30 Jun 17	6,561	1,198	600
31 Mar 17	7,298	1,380	595
31 Dec 16	8,035	1,563	590
30 Sep 16	7,807	1,457	591
30 Jun 16	7,580	1,351	592
31 Mar 16	7,047	1,306	598
31 Dec 15	6,514	1,261	605
30 Sep 15	6,060	1,380	563
30 Jun 15	5,606	1,500	521
31 Mar 15	5,442	1,225	488
31 Dec 14	5,279	951	455
30 Sep 14	5,688	896	455
30 Jun 14	6,097	841	455
31 Mar 14	6,466	1,537	441
31 Dec 13	6,835	2,234	427

양질의 수익: 2329 은(는) 현재 수익성이 없습니다.

이익 마진 증가: 2329 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 2329 은(는) 수익성이 없으며 지난 5년 동안 연간 65.2% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 2329 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: 2329 은(는) 수익성이 없어 지난 해 수익 성장을 Real Estate 업계( -13.2% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: 2329 현재 수익성이 없기 때문에 마이너스 자본 수익률( -2.83% )을 갖습니다.

Glory Health Industry 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Recent updates

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기